DALACINE 600 mg, solution for injection ampoule, 4 ml
Active ingredients: Clindamycin phosphate, Clindamycin
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only, hospital use
Solution for injectionampoule, 4 mlintramusculaire;intraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- DALACINE 600 mg, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 ampoule(s) en verre de 4 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Nov 1995
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69913330CIP75619773CIP133400956197736Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CLINDAMYCINE (PHOSPHATE DE)solution | — | SA |
| CLINDAMYCINE BASEsolution | 600 mg · 4 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.